ATEC Announces Closing of Public Stock Offering
28 October 2023 - 7:05AM
Business Wire
Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of
innovative solutions dedicated to revolutionizing the approach to
spine surgery, today announced the closing of its previously
announced underwritten public offering of 14,300,000 shares of its
common stock at a public offering price of $10.50 per share.
Morgan Stanley, TD Cowen, Barclays and Stifel acted as joint
book-running managers in the offering.
ATEC received gross proceeds from the offering of
$150,150,000.
The shares of common stock were offered pursuant to a shelf
registration statement on Form S-3 (File No. 333-271336) previously
filed with and declared effective by the Securities and Exchange
Commission (the “SEC”). The offering was made by means of a
prospectus supplement and the accompanying prospectus. A
preliminary prospectus supplement, final prospectus supplement and
accompanying prospectus relating to the offering were filed
previously with the SEC and are available on the SEC’s website at
www.sec.gov. The preliminary prospectus supplement, final
prospectus supplement and accompanying base prospectus are
available on the SEC’s website, and may also be obtained from
Morgan Stanley, Attention: Prospectus Department, 180 Varick
Street, 2nd Floor, New York, New York 10014; Cowen and Company,
LLC, 599 Lexington Avenue, New York, New York 10022, by telephone
at (833) 297-2926 or by email at prospectus_ecm@cowen.com; or
Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155
Long Island Avenue, Edgewood, New York 11717, by telephone at
1-888-603-5847 or by email at
barclaysprospectus@broadridge.com.
This press release shall not constitute an offer to sell nor the
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction.
About ATEC
ATEC, through its wholly owned subsidiaries, Alphatec Spine,
Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical
device company dedicated to revolutionizing the approach to spine
surgery through clinical distinction. ATEC’s Organic Innovation
Machine™ is focused on developing new approaches that integrate
seamlessly with the Company’s expanding AlphaInformatiX Platform to
better inform surgery and more safely and reproducibly achieve the
goals of spine surgery. ATEC’s vision is to be the Standard Bearer
in Spine.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231027983349/en/
Company Contact: J. Todd Koning Chief Financial Officer
investorrelations@atecspine.com
Investor/Media Contact: Tina Jacobsen, CFA Investor
Relations (760) 494-6790 investorrelations@atecspine.com
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From Apr 2024 to May 2024
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From May 2023 to May 2024